cabozantinib

Fri, 25 Mar 2022 09:25:28 -0400
Treatment of adult and adolescent patients 12 years of age and older with differentiated thyroid carcinoma (DTC) that has progressed following prior therapy and who are radioactive iodine-refractory or ineligible.